A Potential Role for Glucagon in the Treatment of Drug-Induced Symptomatic Bradycardia
Open Access
- 1 July 1998
- Vol. 114 (1) , 323-326
- https://doi.org/10.1378/chest.114.1.323
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Glucagon Therapy in the Treatment of Symptomatic BradycardiaAnnals of Emergency Medicine, 1997
- A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine modelThe American Journal of Emergency Medicine, 1993
- β-Adrenoreceptor antagonist toxicity: A survey of glucagon availabilityAnnals of Emergency Medicine, 1993
- A Comparison of Amrinone and Glucagon Therapy for Cardiovascular Depression Associated with Propranolol Toxicity in a Canine ModelJournal of Toxicology: Clinical Toxicology, 1992
- Recognition and management of poisoning with beta-adrenergic blocking agentsAnnals of Emergency Medicine, 1984
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and managementAmerican Heart Journal, 1979
- Electrophysiological effects of glucagon on the normal canine heartAmerican Journal of Physiology-Legacy Content, 1972
- Glucagon in Heart Failure and in Cardiogenic ShockCirculation, 1972
- Hemodynamic Evaluation of Glucagon in Symptomatic Heart DiseaseCirculation, 1971
- Cardiac Actions of GlucagonCirculation Research, 1968